Oxidative Medicine and Cellular Longevity / 2016 / Article / Tab 3

Research Article

Glutathione as a Biomarker in Parkinson’s Disease: Associations with Aging and Disease Severity

Table 3

High versus low blood Glu concentrations in PD. In order to evaluate whether blood Glu may be associated with rate of progression, regression analysis is adjusted for age and years since PD diagnosis.

High versus low blood Glu in Parkinson’s disease severity
GSH < 1000 μmol/LGSH ≥ 1000 μmol/L (95% CI)

Unified PD Rating Scale (UPDRS)75.82 (12.19) 65.9 (10.33)0.087 (−11.90, 0.83)
Patient-Reported Outcomes in PD (PRO-PD)1013.46 (365.37)675.53 (381.57)0.012 (−525.28, −67.49)

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.